Associação entre a escala de status funcional com testes funcionais e níveis de ansiedade e depressão em indivíduos pós covid-19.
Introduction: COVID-19 is an acute respiratory infection caused by the infection of the SARS-CoV-2 virus that has caused the contamination of millions of people around the world. The persistence of symptoms after the disease has been discussed due to the impact on the survivors' daily activitie...
Na minha lista:
| Autor principal: | |
|---|---|
| Outros Autores: | |
| Formato: | bachelorThesis |
| Idioma: | pt_BR |
| Publicado em: |
Universidade Federal do Rio Grande do Norte
|
| Assuntos: | |
| Endereço do item: | https://repositorio.ufrn.br/handle/123456789/48417 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
| Resumo: | Introduction: COVID-19 is an acute respiratory infection caused by the infection of the SARS-CoV-2 virus that has caused the contamination of millions of people around the world. The persistence of symptoms after the disease has been discussed due to the impact on the survivors' daily activities. The Post COVID-19 Functional Status Scale (PCFS) was recently created, however, its direct relationship with functional capacity and symptoms have not yet been determined. Objectives: To analyze the association between PCFS in patients after COVID-19 with functional capacity and levels of anxiety and depression, in addition to identifying the PCFS classification of patients with or without comorbidities. Methodology: Cross-sectional study, with post-COVID-19 patients hospitalized or not. The subjects performed the 1-minute sit-and-stand test, the 6-minute walk test and responded to the anxiety and depression scale, in addition to the PCFS. GraphPad Prism software, version 8.0 was used for statistical analysis. Spearman and Mann Whitney tests were used for correlation analysis and intergroup comparison, respectively, in addition to simple linear regression analysis. p<0.05 was considered for statistical significance and a confidence interval of 95%. Results: The findings indicate a negative association between the PCFS scale and the 6MWT in the total sample (r= -0.45 and p= 0.02) and GH (r= -0.54 and p= 0.04), as well as, between the final fatigue at 6MWT in the total sample (r= -0.46) and GH (r= -0.65) both with p=0.01. Furthermore, we found a positive relationship between depression HADS and PCFS in the total sample (r= 0.40 and p= 0.03) and GH (r= 0.71 and p= 0.005). Simple linear regression analysis indicated a dependence with PCFS between 6MWT (r²= 0.21 and p= 0.01) in the total sample, in the final fatigue to 6MWT in the total sample (r²= 0.22 and p= 0.01) and in GH (r²= 0.43 and p= 0.01) and HADS depression (r²= 0.16 and p= 0.03) in the total sample and GH (r²= 0.55 and p= 0.002) with PCFS. Conclusion: The PCFS scale has a negative association with performance on the 6MWT both in hospitalized and non-hospitalized individuals, and the higher the fatigue at the end of this test and the HADS score, the higher the PCFS classification. In addition, patients with comorbidities have more limitations in PCFS than those without comorbidities. |
|---|